GREGORY S BYRD

Allopathic & Osteopathic Physicians|Internal Medicine WOODSTOCK, VA NPI 1396744488

General Payments — all program years on this page

$637.90

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $254.74 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $254.7414

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
PFIZER INC. $45.163
Exact Sciences Corporation $38.912
Novo Nordisk AS $31.912
DEXCOM, INC. $23.321
Lundbeck LLC $21.741
Amgen Inc. $21.691
Lilly USA, LLC $20.771
BOSTON SCIENTIFIC CORPORATION $20.041
GlaxoSmithKline, LLC. $17.051
Acerta Pharma LLC $14.151

By program year

Program yearAmountRecords
2019 $100.997
2020 $119.318
2021 $61.504
2023 $101.366
2024 $254.7414

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092343714 Boston Scientific Corporation $20.04 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096682921 Novo Nordisk Inc $18.60 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096840003 Novo Nordisk Inc $13.31 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105501242 AstraZeneca Pharmaceuticals LP $14.15 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114604325 Exact Sciences Corporation $23.40 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114604329 Exact Sciences Corporation $15.51 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116558745 GlaxoSmithKline, LLC. $17.05 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117215230 Amgen Inc. $21.69 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131809335 PFIZER INC. $14.44 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131862503 PFIZER INC. $13.24 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131950608 PFIZER INC. $17.48 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134991300 Lilly USA, LLC $20.77 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145901840 Lundbeck LLC $21.74 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153302253 Dexcom, Inc. $23.32 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.